The Effects of 4 Week β-alanine Supplementation on Knee Extensor

Status Suspended

Clinical Trial Summary

The older population is the fastest growing age group worldwide, but it is also the most susceptible to chronic diseases and disabilities. One of the most common negative consequences of aging is the decline in muscle mass, strength and power. This is most notable in lower limb muscles. These muscles are required for the performance of daily activities including walking, stair climbing and standing up from sitting. Regular exercise is considered one of the most effective measures to slow, and even reverse the progression of muscle weakness. Nevertheless older adults may notice a decline in their capability to undertake regular exercises, this may be due to a decline in their muscle's ability to buffer pH. Carnosine (made by bonding β-alanine and histidine) has been suggested to contribute to the extension of physical performance, counteracting the decline the muscle's ability to buffer pH. Yet this pH buffering process it largely restricted by the amount of β-alanine available in the human body. β-alanine is already known to decline in older individuals due to a reduction in food products (meat, fish and poultry). Yet through either consumption of β-alanine rich food, or through short-term supplementation, β-alanine is raised, increasing carnosine concentrations. Improved β-alanine levels can potentially advance exercise performance, for example significant improvements in time to exhaustion on both a constant (37%) and incremental (12%) treadmill tests have been demonstrated. It is therefore proposed that via β-alanine supplementation, an individual's perception of their frailty, maintenance of health and independent living can be improved in older individuals.

However, these findings are based on participants, both young and older, who are well-rested with no prior exercise or fatigue to the assessed muscles. It remains unclear if β-alanine supplementation will aid in the buffering of pH when the muscle has already been fatigued. Therefore this investigation hopes to examine the effects of 4 week β-alanine supplementation on lower limb contractile and force properties, pre and post muscle specific fatigue.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Muscle Function

Clinical Trial Details

NCT number	NCT03111979
Study type	Interventional
Source	Nottingham Trent University
Contact
Status	Suspended
Phase	Phase 4
Start date	April 2014
Completion date	October 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04300504` - Muscle in Obesity: Imaging, Function and microRNA
Completed	`NCT01825616` - Vitamin D2, Muscle Damage, NASCAR Pitcrew	N/A
Recruiting	`NCT06379282` - Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia	N/A
Completed	`NCT02991989` - Does Exercise Snacking Improve Muscle Function in Older Adults?	N/A
Recruiting	`NCT06067477` - Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups	N/A
Completed	`NCT05929118` - The Effect of Aquatic Rehabilitation on Knee Function in Anterior Cruciate Ligament Reconstruction Patients.	N/A
Completed	`NCT05397418` - Female Muscle Enhancement	N/A
Not yet recruiting	`NCT04241497` - Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism	N/A
Completed	`NCT03956732` - Effects of Milk Protein and Vitamin D on Children's Growth and Health	N/A
Completed	`NCT02655393` - A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects	Phase 1
Completed	`NCT04563611` - Effect of Exercises on Hamstring Muscle Function, Injury Risk, Agility and Cognitive Function	N/A
Completed	`NCT02858882` - Vitamin D Status and Muscle Function	N/A
Completed	`NCT03283462` - Bioenergetics and Muscle Function Improvement With AMAZ-02 in Elderly Skeletal Muscle (ENERGIZE Trial)	N/A
Completed	`NCT02819505` - β-alanine Supplementation on Knee Extensor Contractile and Force Properties	Phase 4
Completed	`NCT02317536` - A Pilot Clinical Trial on the Efficacy of Two Carnitine-Based Products on Muscle Function in Healthy Older Adults	Phase 2
Recruiting	`NCT05617222` - The Impact of Bed Rest, Aging and NMES on Skeletal Muscle	N/A
Recruiting	`NCT04619784` - Effect of Pilates Application on Abdominal Muscle Function, Core Stability, Musculoskeletal Pain, Quality of Life, Anxiety and Depression in Parkinson's Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effects of 4 Week β-alanine Supplementation on Knee Extensor Contractile and Force Properties in the Over 60s

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms